46 — 7 (45) 2022 — Azimov S.I., Khamdamov B.Z., MODERN CLINICAL AND IMMUNOLOGICAL METHODS FOR THE STUDY OF UROLOGICAL DISEASES ACCOMPANIED BY TUBERCULOSIS

MODERN CLINICAL AND IMMUNOLOGICAL METHODS FOR THE STUDY OF UROLOGICAL DISEASES ACCOMPANIED BY TUBERCULOSIS

Azimov S.I., Bukhara State Medical Institute

Khamdamov B.Z., Bukhara State Medical Institute

Resume

When pulmonary tuberculosis is combined with urological diseases, along with the general condition of the patient, changes in the body’s immune system are noted, which are mainly characterized by a deep total secondary immunodeficiency of the T-link of the immune system. The fact that no significant changes were observed in the humoral or B-link of the immune system of patients indicates the absence of a negative effect of urological diseases on this link of the immune system. The true marker of T-link deficiency is the immunoregulatory index, which can be recommended to determine the development of secondary immunodeficiency of the T-link of the immune system.

Key words: Urological diseases, tuberculosis, immune system

First page

227

Last page

230

For citation: Azimov S.I., Khamdamov B.Z., MODERN CLINICAL AND IMMUNOLOGICAL METHODS FOR THE STUDY OF UROLOGICAL DISEASES ACCOMPANIED BY TUBERCULOSIS //New Day in Medicine 7(45)2022 227-230 https://l.clck.bar/e238f

LIST OF REFERENCES:

1. Azimov S.I. The Effectiveness of the Universal Urological Questionnaire in the Screening of Urological Pathology in patients with Tuberculosis // International Engineering journal for research and development (IEJRD) Vol.5, Special Issue 9 (2020) №:-2349-0721 pp.1-3
2. Naber K.G., Perepanova T.S. Review of the effectiveness and safety of Kanefron® N in the treatment and prevention of urogenital and gestational diseases // RMJ – 2012, No. 18, S. 922
3. Neymark A.I., Suldina A.P., Batanina A.I. Primenenie preparata Kanefron N in complex lechenii chronic pyelonephritis // RMJ – 2014. – 20(6). – S. 23-26.
4. Rashidov Z. R., Mukhtarov Sh. T., Azimov S. I. Vozmojnosti lechebno-profilakticheskoy tactic in good-quality prostate hyperplasia and sick tuberculosis
5. Seytbaev Y. Sh., Parpieva N.N., Djurabaeva M.Kh. s saavt. Characteristics of destructive tuberculosis of the legkix and bolnyx diabetes mellitus type 2 // Tuberculosis and disease of the legkix, 2015. №6. P.132-133
6. Tashpulatova F.K., Mukhtarov D.Z. The method of prognosing the risk of development of secondary reactions and patients with mild tuberculosis caused by medical resistance.
7. Tarasova L.G., Streltsova E.N. Immunological status of sick tuberculosis. Infection and immunity. 2015. T.5., No. 1. -S.85-88.
8. Azimov S.I., Khamdamov B.Z. Immune dysfunctions and their prevention during the use of the drug canefron n in the complex treatment of chronic pyelonephritis /European journal of modern medicine and practice. Vol.2 No.5 (2022).- P.54-58/
9. Rashidov Z.R., Azimov S.I. The Role of the Universal Urological Questionnaire in the Screening of Urological Pathology in Patients with Tuberculosis // American Journal of Medicine and Medical Sciences, 2020 10(10), pp. 769-772
10. EAU Guidelines. Edn. presented at the EAU Annual Congress Barcelona 2019. ISBN 978-94-92671-04-2
11. Khamdamov B. Z., Nuraliev N. A. Pathogenetic approach in complex treatment of diabetic foot syndrome with critical lower limb ischemia // American Journal of Medicine and Medical Sciences. – 2020. – T. 10. – no. 1. – S. 17-24.
12. Shovkun L.A, Kudlay A.V, Osobennosti formirovaniya immunnogo otveta pri tuberculosis s vydeleniem lekarstvenno-chuvstvitelnyx i lekarstvenno-ustoychivyx stammov m. tuberculosis. Tuberculosis and diseases lyogkix, Volume 97, No. 6, 2019. -S.44-49.